BMY is indeed firing on all cylinders; however, it’s important to note that BMY owns only 40% of the worldwide profits on Eliquis (even though it books 100% of the sales).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.